These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 17672900)

  • 21. Uninsured and unstably insured: the importance of continuous insurance coverage.
    Schoen C; DesRoches C
    Health Serv Res; 2000 Apr; 35(1 Pt 2):187-206. PubMed ID: 10778809
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Physician reimbursement levels and adherence to American Academy of Pediatrics well-visit and immunization recommendations.
    McInerny TK; Cull WL; Yudkowsky BK
    Pediatrics; 2005 Apr; 115(4):833-8. PubMed ID: 15805352
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinic provision of contraceptive services to managed care enrollees.
    Frost JJ
    Fam Plann Perspect; 1998; 30(4):156-62. PubMed ID: 9711452
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Six-year follow-up on work force and finances of the United States anesthesiology training programs: 2000 to 2006.
    Kheterpal S; Tremper KK; Shanks A; Morris M
    Anesth Analg; 2009 Jan; 108(1):263-72. PubMed ID: 19095861
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The health status of southern children: a neglected regional disparity.
    Goldhagen J; Remo R; Bryant T; Wludyka P; Dailey A; Wood D; Watts G; Livingood W
    Pediatrics; 2005 Dec; 116(6):e746-53. PubMed ID: 16263972
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Associations between implementation characteristics and evidence-based practice sustainment: a study of the Adolescent Community Reinforcement Approach.
    Hunter SB; Han B; Slaughter ME; Godley SH; Garner BR
    Implement Sci; 2015 Dec; 10():173. PubMed ID: 26701601
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessing Adolescent Substance Abuse Programs with Updated Quality Indicators: The Development of a Consumer Guide for Adolescent Treatment.
    Cacciola JS; Meyers K; Bates SE; Rosenwasser B; Arria A; McLellan AT
    J Child Adolesc Subst Abuse; 2015; 24(3):142-154. PubMed ID: 26417196
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessing the generalizability of the CSAT-sponsored GAIN dataset: are the CSAT sites representative of adolescent treatment programs in the U.S.?
    Hunter SB; Griffin BA; Booth MS; Ramchand R; McCaffrey DF
    J Subst Abuse Treat; 2014 Feb; 46(2):238-43. PubMed ID: 23988191
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An In-Depth Survey of the Screening and Assessment Practices of Highly Regarded Adolescent Substance Abuse Treatment Programs.
    Gans J; Falco M; Schackman BR; Winters KC
    J Child Adolesc Subst Abuse; 2010 Jan; 19(1):33-47. PubMed ID: 20209067
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adolescent-only substance abuse treatment: availability and adoption of components of quality.
    Knudsen HK
    J Subst Abuse Treat; 2009 Mar; 36(2):195-204. PubMed ID: 19000942
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Medicaid reimbursement and the uptake of adolescent vaccines.
    Gowda C; Dempsey AF
    Vaccine; 2012 Feb; 30(9):1682-9. PubMed ID: 22226859
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Does higher cost mean better quality? evidence from highly-regarded adolescent drug treatment programs.
    Schackman BR; Rojas EG; Gans J; Falco M; Millman RB
    Subst Abuse Treat Prev Policy; 2007 Jul; 2():23. PubMed ID: 17672900
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The quality of highly regarded adolescent substance abuse treatment programs: results of an in-depth national survey.
    Brannigan R; Schackman BR; Falco M; Millman RB
    Arch Pediatr Adolesc Med; 2004 Sep; 158(9):904-9. PubMed ID: 15351757
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Organizational and client determinants of cost in outpatient substance abuse treatment.
    Beaston-Blaakman A; Shepard D; Horgan C; Ritter G
    J Ment Health Policy Econ; 2007 Mar; 10(1):3-13. PubMed ID: 17417043
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differences in the cost of antidepressants across state Medicaid programs.
    Kelton CM; Rebelein RP; Heaton PC; Ferrand Y; Guo JJ
    J Ment Health Policy Econ; 2008 Mar; 11(1):33-47. PubMed ID: 18424875
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.